1. Гриневич В. Б., Ласый В. П., Сас Е. И. и др. Метаболический синдром у больных с заболеваниями органов пищеварения: значение для теории и практики. Рос. кардиол. журн. 2003; 1: 74-80.
2. Егорова Е.Г., Звенигородская Л.А., Лазебник Л.Б. Метаболический синдром с позиции гастроэнтеролога. Рус. мед. журн. 2005; 13 (26): 1706–12.
3. van Geenen EJ et al. Nonalcoholic fatty liver disease is related to nonalcoholic fatty pancreas disease. Pancreas 2010; 39: 1185–90.
4. Ogilvie R. The island of langerhans in 19 cases of obesity. J Pathol 1933; 37: 473–81.
5. Olsen TS. Lipomatosis of the pancreas in autopsy material and its relation to age and overweight. Acta Pathol Microbiol Scand 1978; A 86a: 367–73.
6. Lee Y et al. Pancreatic steatosis: harbinger of type 2 diabetes in obese rodents. Int J Obes (Lond.) 2010; 34: 396–400.
7. Smits MM, van Geenen EJM. The clinical significance of pancreatic steatosis. Nat Rev Gastroenterol Hepatol 2011; 8: 169–77.
8. Pinnick KE et al. Pancreatic ectopic fat is characterized by adipocyte infiltration and altered lipid composition. Obesity (Silver Spring) 2008; 16: 522–30.
9. Mathur A et al. Nonalcoholic fatty pancreas disease. HPB (Oxford) 2007; 9: 312–8.
10. Fraulob JC, Ogg-Diamantino R, Fernandes-Santos C et al. A mouse model of metabolic syndrome: insulin resistance, fatty liver and non-alcoholic fatty pancreas disease (NAFPD) in C57BL/6 mice fed a high fat diet. J Clin Biochem Nutr 2010; 46: 212–23.
11. Park CM, Han JK, Kim TK, Choi BI. Fat replacement with absence of acinar and ductal structure in the pancreatic body and tail. J Comput Assist Tomogr 2000; 24: 893–5.
12. Tytgat GN. Hyoscine butylbromide – a review on its parenteral use in acute abdominal spasm and as an aid in abdominal diagnostic and therapeutic procedures. Curr Med Res Opin 2008.
13. Renuka, TR, Robinson R, Paulose CS. Increased insulin secretion by muscarinic M1 and M3 receptor function from rat pancreatic islets in vitro. Neurochem Res 2006; 31: 313–20. [PMID:16733808]
14. Renuka TR, Savitha B, Paulose CS. Muscarinic M1 and M3 receptor binding alterations in pancreas during pancreatic regeneration of young rats. Endocrine research 2005; 31 (4): 259–70.
15. Renuka TR, Das Ani V, Paulose CS. Alterations in the muscarinic M1 and M3 receptor gene expression in the brain stem during pancreatic regeneration and insulin secretion in weanling rats. Life sciences 2004; 75 (19): 2269–80.
16. Гриневич В.Б., Сас Е.И., Кравчук Ю.А. и др. Новые подходы к лечению хронического системного воспаления и синдрома инсулинорезистентности у больных неалкогольной жировой болезнью печени. РМЖ. 2011; 19 (2): 1–7.
17. Гриневич В.Б., Сас Е.И., Карев Ф.А. и др. Метаболические эффекты селективного М-холинолитика (гиосцина бутилбромида) у больных с хроническим панкреатитом. Гастроэнтерология Санкт-Петербурга. 2010; 10: 2–7.